Adaptin Bio (APTN) Stock Price, News & Analysis
Company Description
APTN has gained 11.6% over the past year. Shares last traded at $6.25.
On a trailing twelve-month basis, Adaptin Bio and diluted earnings per share of $-0.66.
This page collects what Stock Titan holds for APTN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Adaptin Bio (APTN) last traded at $6.25. Over the past 12 months, APTN has gained 11.6%.
Latest News
Adaptin Bio has 1 recent news article. View all APTN news →
SEC Filings
Adaptin Bio has filed 5 recent SEC filings, including 2 Form 424B3, 1 Form POS AM, 1 Form 10-K/A, 1 Form 10-Q. The most recent filing was submitted on July 21, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all APTN SEC filings →
Financial Highlights
Diluted earnings per share stood at $-0.66. With a current ratio of 0.29, short-term liquidity bears monitoring.